ATGAM Versus OKT3 Induction Therapy in Cadaveric Kidney Transplantation: Patient and Graft Survival, CD3 Subset, Infection, and Cost Analysis 1 1 This study was supported by a grant from Ortho-Biotech, Raritan, NJ.
Titel:
ATGAM Versus OKT3 Induction Therapy in Cadaveric Kidney Transplantation: Patient and Graft Survival, CD3 Subset, Infection, and Cost Analysis 1 1 This study was supported by a grant from Ortho-Biotech, Raritan, NJ.
Auteur:
Kumar, M.S.A Cahill, K Kumar, A.M.S Panigrahi, D Seirka, D Singleton, R Al-Abdullah, I.H Laskow, D.A